Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Past Updates from the Clinician Registry Listserv

Update Sent September 11, 2006

NOTE: This document is provided for historical purposes only and may not provide our most accurate and up-to-date information. The most current Clinician's information can be found on the Clinician Home Page.

Today's topics include:

COCA Conference Call

Upcoming Call - BioSense

Date: Tuesday, September 26, 2006
Time: 1:00 p.m. - 2:00 p.m. ET
Topic: Update on BioSense
Speaker: Lynn Steele, MS, CIC

Toll-Free Dial-in Number: (888) 889-4431
Passcode: BioSense

Lynn Steele, MS, CIC, is the Director of the Division of Emergency Preparedness and Response (DEPR) in the National Center for Public Health Informatics at the Centers for Disease Control and Prevention (CDC). In her current position as Division Director, she is also the BioSense program lead.
Ms. Steele has been at CDC since 1998 serving as an epidemiologist in the National Center for Infectious Diseases (NCID), Division of Healthcare Quality Promotion and subsequently serving as a special advisor to CDC’s Associate Director for Communication, to develop the clinician communication and outreach strategy for CDC’s new Emergency Communication System. Prior to joining CDC, Ms. Steele worked and consulted in healthcare epidemiology for 10 years in a variety of practice settings.

Objectives for the call are that participants will:

  • Understand the vision and approach for building BioSense
  • Be familiar with the 2006 implementation goals and progress toward those goals
  • Have increased awareness of the evaluation plans and communication channels now in place

Slides will be posted in upcoming Updates and on the COCA website: http://www.bt.cdc.gov/coca/callinfo.asp.

Avian Influenza

Satellites Help Scientists Track Migratory Birds: GPS the Latest Tool in Fight Against Avian Influenza - September 6 - USGS News Release
http://www.usgs.gov/newsroom/article.asp?ID=1547

Confirmatory Tests Being Conducted on Pennsylvania Wild Bird Samples - September 2 - USDA News Release
The U.S. Departments of Agriculture and Interior announced on September 2, 2006 that the presence of the H5 and N1 avian influenza subtypes in samples from wild mallard ducks in Pennsylvania. Testing has ruled out the possibility of this being the highly pathogenic H5N1 strain that has spread through birds in Asia, Europe and Africa. Test results thus far indicate this is low pathogenic avian influenza (LPAI), which poses no threat to human health.
http://www.usda.gov/wps/portal/usdahome?contentidonly=true&contentid=2006/09/0337.xml

Avian Influenza Low Pathogenic H5N1 vs. Highly Pathogenic H5N1 Latest Update - September 1, 2006 - USDA Fact Sheet
There are two types of avian influenza (AI) that are identified as H5N1. A difference exists in the virus classification; one is low pathogenic (LPAI) and the other is highly pathogenic (HPAI). Pathogenicity refers to the ability of the virus to produce disease.
USDA Fact Sheet - Avian Influenza

Confirmatory Tests Being Conducted on Maryland Wild Bird Fecal Samples - September 1 - USDA News Release
The U.S. Departments of Agriculture and Interior announced on September 1st that the presence of the H5N1 avian influenza subtype has been detected in fecal samples from wild birds in Maryland.
http://www.usda.gov/wps/portal/usdahome?contentidonly=true&contentid=2006/09/0335.xml

Seasonal Influenza

Recommendations for Using Inactivated and Live, Attenuated Influenza Vaccines - September 8
The inactivated influenza vaccine and LAIV can be used to reduce the risk for influenza virus infection and its complications. TIV is Food and Drug Administration (FDA)-approved for persons aged >6 months, including those with high-risk conditions, whereas LAIV is approved only for use among healthy persons aged 5-49 years.
http://www.cdc.gov/flu/professionals/vaccination/recommendations.htm

Influenza Vaccine Supply and Timing of Annual Influenza Vaccination - September 8
The annual supply of influenza vaccine and the timing of its distribution cannot be guaranteed in any year. Currently, influenza vaccine manufacturers are projecting that approximately 100 million doses of influenza vaccine will be available in the United States for the 2006--07 influenza season, an amount that is approximately 16% more doses than were available for the 2005--06 season. An additional 15 million--20 million doses might be available if a new vaccine is licensed in 2006.
http://www.cdc.gov/flu/professionals/vaccination/timing.htm

Efficacy and Effectiveness of Live, Attenuated Influenza Vaccine (LAIV) - September 8
The immunogenicity of the approved LAIV has been assessed in multiple studies, which included approximately 100 children aged 5--17 years and approximately 300 adults aged 18--49 years. LAIV virus strains replicate primarily in nasopharyngeal epithelial cells. The protective mechanisms induced by vaccination with LAIV are not completely understood but appear to involve both serum and nasal secretory antibodies. No single laboratory measurement closely correlates with protective immunity induced by LAIV.
http://www.cdc.gov/flu/professionals/vaccination/laivefficacy.htm

Vaccination of Close Contacts of Persons at High Risk for Complications from Influenza - September 8
Close contacts of persons at high risk for complications from influenza should receive influenza vaccine to reduce transmission of wild-type influenza viruses to persons at high risk. Use of inactivated influenza vaccine is preferred for vaccinating household members, health-care workers, and others who have close contact with severely immunocompromised persons (e.g., patients with hematopoietic stem cell transplants) during those periods in which the immunocompromised person requires care in a protective environment.
http://www.cdc.gov/flu/professionals/vaccination/closecontacts.htm

More than 100 Million Doses of Influenza Vaccine Expected To Be Available This Year - September 6 - CDC Press Release
The Centers for Disease Control and Prevention (CDC) announced on September 6th that influenza (flu) vaccine manufacturers are expecting to produce and distribute more than 100 million doses of influenza vaccines in the United States between now and early January, 2007.
http://www.cdc.gov/od/oc/media/pressrel/r060906b.htm

Rabies

Horse stabled at Tennessee Walking Horse 2006 National Celebration Tested Positive for Rabies - September 9 - CDC Health Advisory
The Tennessee Department of Health (TDH) with the assistance of the Centers for Disease Control and Prevention (CDC) are notifying the approximately 150,000 persons who attended the Tennessee Walking Horse National Celebration in Shelbyville of a confirmed case of rabies in a horse stabled on the grounds during the event.
http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00248


Our Clinician Communication Team is committed to excellence in reporting our weekly updates.  Please e-mail coca@cdc.gov should you note any written errors or discrepancies.

If you need to unsubscribe or update your information, please go to our website: http://www.bt.cdc.gov/clinregistry

If you need further information or technical help, please send an e-mail message to: coca@cdc.gov

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    24 Hours/Every Day
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov

A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #